Abstract:Major depressive disorder (MDD) is frequently characterized as a disorder of the disconnection syndrome. Diffusion tensor imaging (DTI) has played a critical role in supporting this view, with much investigation providing a large amount of evidence of structural connectivity abnormalities in the disorder. Recent research on the human connectome combined neuroimaging techniques with graph theoretic methods to highlight the disrupted topological properties of large-scale structural brain networks under depression, involving global metrics (e.g., global and local efficiencies), and local nodal properties (e.g., degree and betweenness), as well as other related metrics, including a modular structure, assortativity, and (rich) hubs. Here, we review the studies of white matter networks in the case of MDD with the application of these techniques, focusing principally on the consistent findings and the clinical significance of DTI-based network research, while discussing the key methodological issues that frequently arise in the field. The already published literature shows that MDD is associated with a widespread structural connectivity deficit. Topological alteration of structural brain networks in the case of MDD points to decreased overall connectivity strength and reduced global efficiency as well as decreased small-worldness and network resilience. These structural connectivity disturbances entail potential functional consequences, although the relationship between the two is very sophisticated and requires further investigation. In summary, the present study comprehensively maps the structural connectomic disturbances in patients with MDD across the entire brain, which adds important weight to the view suggesting connectivity abnormalities of this disorder and highlights the potential of network properties as diagnostic biomarkers in the psychoradiology field. Several common methodological issues of the study of DTI-based networks are discussed, involving sample heterogeneity and fiber crossing problems and the tractography algorithms. Finally, suggestions for future perspectives, including imaging multimodality, a longitudinal study and computational connectomics, in the further study of white matter networks under depression are given. Surmounting these challenges and advancing the research methods will be required to surpass the simple mapping of connectivity changes to illuminate the underlying psychiatric pathological mechanism.

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Application of multi-parameter magnetic resonance imaging in major depressive disorder

Connectome Analysis of Functional and Structural Hemispheric Brain Networks in Major Depressive Disorder

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Molecular imaging in patients with mood disorders: a review of PET findings

Translational Application of Neuroimaging in Major Depressive Disorder: a Review of Psychoradiological Studies

Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.

The Role of Neuroimaging in the Diagnosis and Treatment of Depressive Disorder: A Recent Review.

Brain structural and functional changes in patients with major depressive disorder: a literature review

Pharmacological treatment-associated brain structural and functional alterations in major depressive disorder: A narrative review

Morphologic and Functional Connectivity Alterations in Patients with Major Depressive Disorder

Neuroimaging Advance in Depressive Disorder.

Elucidating genetic and molecular basis of altered higher-order brain structure-function coupling in major depressive disorder

Brain structure alterations in depression: Psychoradiological evidence

White Matter-Based Structural Brain Network of Major Depression.

Characterization of Major Depressive Disorder Using a Multiparametric Classification Approach Based on High Resolution Structural Images.

High-field Magnetic Resonance Imaging of Structural Alterations in First-Episode, Drug-Naive Patients with Major Depressive Disorder

Structural Neuroimaging and Molecular Signatures of Drug‐Naive Depression With Melancholic Features

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

Association Analysis of Gene Expression and Brain Image Identifies Gene Signatures in Major Depression Disorder

Neural Correlates of Severity in Major Depressive Disorder: A Combined Structural and Resting-State Functional MRI Study